Amphastar Pharmaceuticals, Inc.

Healthcare

NASDAQ:AMPH · NASDAQ Global Select

Market Cap $885.83M Beta 0.90 P/E (TTM) 11.5

$20.09 -2.14%

-$0.44 today

52W Low $16.65High $31.26

Vol 0.38M · Avg 0.59M

EPS (TTM)$1.75

Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-22.19%

Period High

$30.81

Period Low

$16.87

Latest

$20.09

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Dynavax Technologies Corporation

DVAX

$1.82B

Syndax Pharmaceuticals, Inc.

NASDAQ:SNDX

$1.62B

Harrow Health, Inc.

NASDAQ:HROW

$1.40B

AdaptHealth Corp.

NASDAQ:AHCO

$1.38B

Inhibrx Biosciences, Inc.

NASDAQ:INBX

$1.35B

Collegium Pharmaceutical, Inc.

NASDAQ:COLL

$1.12B

CureVac N.V.

CVAC

$1.05B

Pacira BioSciences, Inc.

NASDAQ:PCRX

$904.31M

Beta Bionics, Inc.

NASDAQ:BBNX

$647.48M

Embecta Corp.

NASDAQ:EMBC

$183.92M

What is the latest AMPH filing?

The latest filing shown is 4 dated Jun 3, 2026.

How many recent filings does AMPH have?

Intrinsic Alpha currently shows 20 recent filings for AMPH.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.